Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP668344.RAWcT-3rXIJ71Ra_h3GNHs1wYg8u9U7pf7_sHFEFNQqhw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP668344.RAWcT-3rXIJ71Ra_h3GNHs1wYg8u9U7pf7_sHFEFNQqhw130_assertion type Assertion NP668344.RAWcT-3rXIJ71Ra_h3GNHs1wYg8u9U7pf7_sHFEFNQqhw130_head.
- NP668344.RAWcT-3rXIJ71Ra_h3GNHs1wYg8u9U7pf7_sHFEFNQqhw130_assertion description "[To the best of our knowledge, this is the first prospective analysis in which the prognostic impact of a relatively high number of antigenic markers has been simultaneously analyzed in a large series of uniformly treated patients, showing that the expression of several antigens (particularly CD28 and CD117) on bone marrow plasma cells from patients with MM can help to identify patients at high risk of progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668344.RAWcT-3rXIJ71Ra_h3GNHs1wYg8u9U7pf7_sHFEFNQqhw130_provenance.
- NP668344.RAWcT-3rXIJ71Ra_h3GNHs1wYg8u9U7pf7_sHFEFNQqhw130_assertion evidence source_evidence_literature NP668344.RAWcT-3rXIJ71Ra_h3GNHs1wYg8u9U7pf7_sHFEFNQqhw130_provenance.
- NP668344.RAWcT-3rXIJ71Ra_h3GNHs1wYg8u9U7pf7_sHFEFNQqhw130_assertion SIO_000772 18443352 NP668344.RAWcT-3rXIJ71Ra_h3GNHs1wYg8u9U7pf7_sHFEFNQqhw130_provenance.
- NP668344.RAWcT-3rXIJ71Ra_h3GNHs1wYg8u9U7pf7_sHFEFNQqhw130_assertion wasDerivedFrom befree-2016 NP668344.RAWcT-3rXIJ71Ra_h3GNHs1wYg8u9U7pf7_sHFEFNQqhw130_provenance.
- NP668344.RAWcT-3rXIJ71Ra_h3GNHs1wYg8u9U7pf7_sHFEFNQqhw130_assertion wasGeneratedBy ECO_0000203 NP668344.RAWcT-3rXIJ71Ra_h3GNHs1wYg8u9U7pf7_sHFEFNQqhw130_provenance.